Evidence map›Paper›PMID 39632802›Full record

ArticleHuman genome variation2024

High-resolution genetic analysis of whole APC gene deletions: a report of two cases and patient characteristics.

Hiroki Tanabe, Yasuyuki Koshizuka, Kazuyuki Tanaka, Kenji Takahashi, Masami Ijiri, Keitaro Takahashi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima, Takeo Sarashina and 5 more

Abstract read
In one paragraph

Article in Human genome variation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hiroki TanabeOncology Center, Asahikawa Medical University Hospital, Asahikawa, Japan. tant@asahikawa-med.ac.jp.ORCID http://orcid.org/0000-0001-9029-5081
Yasuyuki KoshizukaDepartment of Surgery, Asahikawa-Kosei general Hospital, Asahikawa, Japan.
Kazuyuki TanakaDepartment of Gastroenterology, Asahikawa-Kosei General Hospital, Asahikawa, Japan.
Kenji TakahashiGenetic Oncology Department, Asahikawa Medical University Hospital, Asahikawa, Japan.
Masami IjiriDepartment of Gastroenterology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
Keitaro TakahashiDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
Katsuyoshi AndoGenetic Oncology Department, Asahikawa Medical University Hospital, Asahikawa, Japan.
Nobuhiro UenoDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
Shin KashimaDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
Takeo SarashinaOncology Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
Kentaro MoriichiDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
Kenrokuro MitsubeDepartment of Obstetrics and Gynecology, Asahikawa-Kosei General Hospital, Asahikawa, Japan.
Yusuke MizukamiDepartment of Genetic Counseling, Asahikawa Medical University Hospital, Asahikawa, Japan.
Mikihiro FujiyaDivision of Gastroenterology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
Yoshio MakitaDepartment of Genetic Counseling, Asahikawa Medical University Hospital, Asahikawa, Japan.ORCID http://orcid.org/0000-0002-0341-5709

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome caused by germline variants in the APC gene, leading to the development of numerous colorectal polyps and significantly increases the risk of colorectal cancer. A diagnosis is typically made using colonoscopy, and genetic testing can assist in patient surveillance and carrier identification. Recent advances include the use of whole-genome array comparative genomic hybridization (a-CGH), which provides better resolution of genetic imbalances. We aimed to explore the specific features of FAP patients with whole APC gene deletions using high-resolution a-CGH and to compare patient characteristics. Two polyposis patients with whole APC deletions were identified, and the lost genetic sizes ranged from 0.3-1.1 Mb. Nervous abnormalities were a characteristic symptom in a patient with a 1.1 Mb loss. A patient with an approximately 0.3 Mb loss, which included the entire APC gene, presented a polyposis phenotype without intellectual disability. The comparison of genetic losses, with or without intellectual disability, revealed 7 genetic changes. Consequently, EPB41L4A is a candidate gene associated with the neurogenic phenotype.

Identifiers

PMID39632802
PMCPMC11618449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.